Skip to main content

Table 3 Patient Risk Factors at Baseline for Visual Impairment

From: Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy

  Risk of Visual Impairment > 0.3logMAR Risk of Visual Impairment ≥1.0 logMAR
OR (95%CI) p (0.05)   p (0.05)
Demographics
 Age at uveitis diagnosis 0.97 (0.87–1.08) 0.56 1.02 (0.88–1.19) 0.76
 Bilateral Disease 1.23 (0.46–3.34) 0.68 0.45 (0.12–1.65) 0.23
 Female 1.43 (0.61–3.36) 0.41 1.24 (0.38–4.12) 0.72
 Tertiary Referral 2.71 (1.12–6.56) 0.03 4.59 (0.98–21.47) 0.05
Aetiology
 JIA 2.05 (0.88–4.77) 0.10 2.15 (0.62–7.43) 0.23
 Idiopathic 0.54 (0.23–1.29) 0.16 0.23 (0.05–1.09) 0.07
Uveitis Characteristics
 Anterior Uveitis 0.89 (0.37–2.14) 0.80 0.89 (0.26–3.07) 0.85
 Bilateral Disease 1.23 (0.46–3.34) 0.68 0.45 (0.12–1.65) 0.23
Complications at Baseline
 Band keratopathy 1.24 (0.24–6.37) 0.80 1.12 (0.15–8.53) 0.92
 Cataracts 1.43 (0.29–6.99) 0.66 5.16 (0.91–29.23) 0.06
 Posterior synechiae 0.84 (0.26–2.71) 0.77 4.91 (1.38–17.39) 0.01
 Elevated IOP 0.35 (0.05–2.51) 0.29 1.00  
 Macular oedema 1.09 (0.12–10.07) 0.94 1.00  
 Hypotony 2.20 (0.19–25.31) 0.53 7.08 (0.64–78.00) 0.11
 Optic disc swelling 0.98 (0.29–3.30) 0.97 2.05 (0.47–8.88) 0.34